Literature DB >> 34953540

Transmissibility of SARS-CoV-2 among fully vaccinated individuals.

Carlos Franco-Paredes1.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 34953540      PMCID: PMC8694744          DOI: 10.1016/S1473-3099(21)00768-4

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
Vaccine effectiveness studies have conclusively demonstrated the benefit of COVID-19 vaccines in reducing individual symptomatic and severe disease, resulting in reduced hospitalisations and intensive care unit admissions. However, the impact of vaccination on transmissibility of SARS-CoV-2 needs to be elucidated. A prospective cohort study in the UK by Anika Singanayagam and colleagues regarding community transmission of SARS-CoV-2 among unvaccinated and vaccinated individuals provides important information that needs to be considered in reassessing vaccination policies. This study showed that the impact of vaccination on community transmission of circulating variants of SARS-CoV-2 appeared to be not significantly different from the impact among unvaccinated people.2, 3 The scientific rationale for mandatory vaccination in the USA relies on the premise that vaccination prevents transmission to others, resulting in a “pandemic of the unvaccinated”. Yet, the demonstration of COVID-19 breakthrough infections among fully vaccinated health-care workers (HCW) in Israel, who in turn may transmit this infection to their patients, requires a reassessment of compulsory vaccination policies leading to the job dismissal of unvaccinated HCW in the USA. Indeed, there is growing evidence that peak viral titres in the upper airways of the lungs and culturable virus are similar in vaccinated and unvaccinated individuals.2,3,5–7 A recent investigation by the US Centers for Disease Control and Prevention of an outbreak of COVID-19 in a prison in Texas showed the equal presence of infectious virus in the nasopharynx of vaccinated and unvaccinated individuals. Similarly, researchers in California observed no major differences between vaccinated and unvaccinated individuals in terms of SARS-CoV-2 viral loads in the nasopharynx, even in those with proven asymptomatic infection. Thus, the current evidence suggests that current mandatory vaccination policies might need to be reconsidered, and that vaccination status should not replace mitigation practices such as mask wearing, physical distancing, and contact-tracing investigations, even within highly vaccinated populations. I declare no competing interests.
  5 in total

1.  Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.

Authors:  Anika Singanayagam; Seran Hakki; Jake Dunning; Kieran J Madon; Michael A Crone; Aleksandra Koycheva; Nieves Derqui-Fernandez; Jack L Barnett; Michael G Whitfield; Robert Varro; Andre Charlett; Rhia Kundu; Joe Fenn; Jessica Cutajar; Valerie Quinn; Emily Conibear; Wendy Barclay; Paul S Freemont; Graham P Taylor; Shazaad Ahmad; Maria Zambon; Neil M Ferguson; Ajit Lalvani
Journal:  Lancet Infect Dis       Date:  2021-10-29       Impact factor: 25.071

2.  What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant?

Authors:  Annelies Wilder-Smith
Journal:  Lancet Infect Dis       Date:  2021-10-29       Impact factor: 25.071

3.  Outbreak of SARS-CoV-2 B.1.617.2 (Delta) Variant Infections Among Incarcerated Persons in a Federal Prison - Texas, July-August 2021.

Authors:  Liesl M Hagan; David W McCormick; Christine Lee; Sadia Sleweon; Lavinia Nicolae; Thomas Dixon; Robert Banta; Isaac Ogle; Cristen Young; Charles Dusseau; Shawn Salmonson; Charles Ogden; Eric Godwin; TeCora Ballom; Tara Ross; Hannah Browne; Jennifer L Harcourt; Azaibi Tamin; Natalie J Thornburg; Hannah L Kirking; Phillip P Salvatore; Jacqueline E Tate
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-09-24       Impact factor: 17.586

4.  Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.

Authors:  Moriah Bergwerk; Tal Gonen; Yaniv Lustig; Sharon Amit; Marc Lipsitch; Carmit Cohen; Michal Mandelboim; Einav Gal Levin; Carmit Rubin; Victoria Indenbaum; Ilana Tal; Malka Zavitan; Neta Zuckerman; Adina Bar-Chaim; Yitshak Kreiss; Gili Regev-Yochay
Journal:  N Engl J Med       Date:  2021-07-28       Impact factor: 91.245

  5 in total
  5 in total

1.  Error in key model input.

Authors:  Richard Schabas
Journal:  CMAJ       Date:  2022-06-20       Impact factor: 16.859

2.  Human Superantibodies to 3CLpro Inhibit Replication of SARS-CoV-2 across Variants.

Authors:  Kittirat Glab-Ampai; Kanasap Kaewchim; Thanatsaran Saenlom; Watayagorn Thepsawat; Kodchakorn Mahasongkram; Nitat Sookrung; Wanpen Chaicumpa; Monrat Chulanetra
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

Review 3.  From HIV to COVID-19, Molecular mechanisms of pathogens' trade-off and persistence in the community, potential targets for new drug development.

Authors:  Antoine AbdelMassih; Abrar Sedky; Ahmed Shalaby; AlAmira-Fawzia Shalaby; Alia Yasser; Aya Mohyeldin; Basma Amin; Basma Saleheen; Dina Osman; Elaria Samuel; Emmy Abdelfatah; Eveen Albustami; Farida ElGhamry; Habiba Khaled; Hana Amr; Hanya Gaber; Ismail Makhlouf; Janna Abdeldayem; Jana Waleed El-Beialy; Karim Milad; Laila El Sharkawi; Lina Abosenna; Madonna G Safi; Mariam AbdelKareem; Marwa Gaber; Mirna Elkady; Mohamed Ihab; Nora AbdelRaouf; Rawan Khaled; Reem Shalata; Rudayna Mahgoub; Sarah Jamal; Seif El-Din El Hawary; Shady ElRashidy; Sherouk El Shorbagy; Tony Gerges; Yara Kassem; Yasmeen Magdy; Yasmin Omar; Yasmine Shokry; Aya Kamel; Rafeef Hozaien; Nadine El-Husseiny; Meryam El Shershaby
Journal:  Bull Natl Res Cent       Date:  2022-07-06

4.  The Significance of Angling in Stress Reduction during the COVID-19 Pandemic-Environmental and Socio-Economic Implications.

Authors:  Emil Andrzej Karpiński; Andrzej Robert Skrzypczak
Journal:  Int J Environ Res Public Health       Date:  2022-04-05       Impact factor: 3.390

5.  Modeling the potential economic benefits of an oral SARS-CoV-2 vaccine during an outbreak of COVID-19.

Authors:  Bryan Patenaude; Jeromie Ballreich
Journal:  BMC Public Health       Date:  2022-09-22       Impact factor: 4.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.